|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group. |
| 公司地址
| Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543 |
| 電話號碼
| +1 609 252-4621 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.bms.com |
| 員工數量
| 32500 |
| Mr. Phil Holzer |
Senior Vice President, Principal Accounting Officer and Controller |
-- |
11/02/2026 |
| Ms. Sandra Leung |
Executive Vice President and General Counsel |
美元 1.15M |
18/02/2025 |
| Mr. David V. Elkins |
Executive Vice President and Chief Financial Officer |
美元 1.12M |
11/02/2026 |
| Dr. Christopher S. Boerner, PhD |
Chairman of the Board and Chief Executive Officer |
美元 1.54M |
11/02/2026 |
| Mr. Adam Lenkowsky |
Executive Vice President and Chief Commercialization Officer |
-- |
11/02/2026 |
| Dr. Cristian Massacesi, M.D. |
Executive Vice President, Chief Medical Officer and Head of Development |
-- |
11/02/2026 |
| Mr. Hiroshi Chris Shibutani, M.D. |
Executive Vice President and Chief Strategy Officer |
-- |
11/02/2026 |
| Mr. Benjamin J. Hickey, M.B.A. |
President, RayzeBio Organization |
-- |
11/02/2026 |
| Ms. Amanda Ahn Poole |
Executive Vice President and Chief People Officer |
-- |
11/02/2026 |
| Ms. Cari Gallman |
Executive Vice President, General Counsel and Chief Policy Officer |
-- |
11/02/2026 |
| Ms. Wendy Short Bartie |
Executive Vice President, Corporate Affairs |
-- |
11/02/2026 |
| Ms. Lynelle Hoch |
President, Cell Therapy Organization |
-- |
11/02/2026 |
| Ms. Karin Shanahan |
Executive Vice President, Chief Supply Chain and Operations |
美元 1.01M |
11/02/2026 |
| Dr. Robert M. Plenge, M.D.,PhD |
Executive Vice President, Chief Research Officer and Head of Research |
-- |
11/02/2026 |
| Mr. Gregory Scott Meyers |
Executive Vice President, Chief Digital Officer and Chief Technology Officer |
-- |
11/02/2026 |
|
|
| Mr. Derica W. Rice |
Independent Director |
11/02/2026 |
| Ms. Phyllis R. Yale |
Independent Director |
11/02/2026 |
| Ms. Paula A. Price |
Independent Director |
11/02/2026 |
| Mr. Peter J. Arduini |
Independent Director |
11/02/2026 |
| Dr. Christopher S. Boerner, PhD |
Chairman of the Board and Chief Executive Officer |
11/02/2026 |
| Dr. Julia A. Haller, M.D. |
Independent Director |
11/02/2026 |
| Mr. Theodore R. Samuels |
Lead Independent Director |
11/02/2026 |
| Dr. Karen H. Vousden, PhD |
Independent Director |
11/02/2026 |
| Dr. Manuel Hidalgo Medina, M.D.,PhD |
Independent Director |
11/02/2026 |
| Mr. Michael R. McMullen |
Independent Director |
11/02/2026 |
| Dr. Deepak L. Bhatt, M.B.A.,M.D.,M.P.H. |
Independent Director |
11/02/2026 |
|
|
|
|
